Morpholino

MO5-pink1

ID
ZDB-MRPHLNO-101007-5
Name
MO5-pink1
Previous Names
  • exon 3 intron 3 (1)
Target
Sequence
5' - TCACAACCTACCCGTTCAAAGTCAG - 3'
ZFIN BLAST NCBI BLAST Ensembl UCSC BLAT
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
Splice-blocking MO.
Genome Resources
None
Target Location
Genome Build: GRCz11Chromosome: 23
Genomic Features
No data available
Expression
Gene expression in Wild Types + MO5-pink1
Expressed Gene Anatomy Figures
arr3a Fig. 1 from Priyadarshini et al., 2013
atp1a2a Fig. 1 from Priyadarshini et al., 2013
cat Fig. 1 from Priyadarshini et al., 2013
cryaa Fig. 1 from Priyadarshini et al., 2013
dbx1a Fig. 1 from Priyadarshini et al., 2013
1 - 5 of 22 Show all
Phenotype
Phenotype resulting from MO5-pink1
Phenotype Fish Figures
brain proliferative region increased size, abnormal WT + MO5-pink1 Fig. 2 from Priyadarshini et al., 2013
catalase activity decreased process quality, abnormal WT + MO5-pink1 Fig. 4 from Priyadarshini et al., 2013
diencephalon dopaminergic neuron decreased amount, abnormal WT + MO5-pink1 Fig. 4,  Fig. 5,  Fig. 6 from Sallinen et al., 2010
heart contraction decreased process quality, abnormal WT + MO5-pink1 Fig. 4 from Priyadarshini et al., 2013
nucleate erythrocyte increased amount, abnormal WT + MO5-pink1 Fig. 5 from Priyadarshini et al., 2013
1 - 5 of 10 Show all
Phenotype of all Fish created by or utilizing MO5-pink1
Phenotype Fish Conditions Figures
heart contraction decreased process quality, abnormal WT + MO5-pink1 standard conditions Fig. 4 from Priyadarshini et al., 2013
catalase activity decreased process quality, abnormal WT + MO5-pink1 standard conditions Fig. 4 from Priyadarshini et al., 2013
regulation of reactive oxygen species metabolic process disrupted, abnormal WT + MO5-pink1 standard conditions Fig. 4 from Priyadarshini et al., 2013
vascular endothelial growth factor signaling pathway cellular spatiotemporal quality, abnormal WT + MO5-pink1 standard conditions Fig. 2 from Priyadarshini et al., 2013
nucleate erythrocyte increased amount, abnormal WT + MO5-pink1 chemical treatment: N-acetyl-L-cysteine Fig. 5 from Priyadarshini et al., 2013
1 - 5 of 11 Show all
Citations
TSV
1 - 4 of 4
Show
Your Input Welcome
We welcome your input and comments. Please use this form to recommend updates to the information in ZFIN. We appreciate as much detail as possible and references as appropriate. We will review your comments promptly.